M. Hebeisen

Type de document

Articles (17) Recensions (3)

Co-auteur

Date

Source

Mot-clé

T cells (13) Cells (13) cancer (7) Cancer (7) Human beings (7) Impact (7) Cancer (7) Receptors (7) Patients (6) Immunotherapy (6) Evaluation (6) Tax assessment (6) Patients (6) Immunotherapy (6) dose (5) Expression (5) Quality (5) étable (4) immunité (4) cytotoxicité (4) Motion (4) Mechanics, Analytic (4) Immunity (4) Dynamics (4) Cellular therapy (4) Cell physiology (4) Use (4) puits (3) spectacle (3) modèle (3)

Documents écrit par M. Hebeisen (17) | parle de M. Hebeisen (0)

CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity.
P. Baumgaertner et al. (10 août 2022)
Constant regulation for stable CD8 T-cell functional avidity and its possible implications for cancer immunotherapy.
C.B. Gilfillan et al.
Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4+ T cells.
B. Carreres et al.
Murine CD8 T-cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen density.
C.B. Gilfillan et al.
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
M.N. Duong et al. (5 nov. 2019)
NK cells specifically TCR-dressed to kill cancer cells.
N. Mensali et al.
Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis.
M. Hebeisen et al. (2019)
High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence.
L. Carretero-Iglesia et al. (2019)
TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency.
M. Allard et al. (20 juil. 2017)
Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.
R. Micheroli et al. (19 juil. 2017)
Heterogeneity assessment of functional T cell avidity.
K. Ioannidou et al. (13 mars 2017)
Fine-Tuning of Optimal TCR Signaling in Tumor-Redirected CD8 T Cells by Distinct TCR Affinity-Mediated Mechanisms
D. Presotto et al. (2017)
Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens.
M. Hebeisen et al. (2015)
Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR-Ligand Off-Rates Measurements on Living Cells.
M. Hebeisen et al. (2015)
MicroRNA-155 Is Required for Effector CD8(+) T Cell Responses to Virus Infection and Cancer.
J.C. Dudda et al. (2013)
Molecular insights for optimizing T cell receptor specificity against cancer.
M. Hebeisen et al. (2013)
SHP-1 phosphatase activity counteracts increased T cell receptor affinity.
M. Hebeisen et al. (2013)